Surgery after Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

被引：0
|
作者：
Bertani, E. [1 ]
Chiappa, A. [1 ]
Fazio, N. [1 ]
Grana, C. [1 ]
Bodei, L. [1 ]
Falconi, M. [2 ]
Ravizza, D. [1 ]
Spada, F. [1 ]
Andreoni, B. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
[2] Univ Politecn Marche, Pancreas Surg Unit, Ancona, Italy
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
neuroendocrine tumors; peptide receptor radionuclide therapy; surgery; survival; progression-free survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O2
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [1] Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Abou Jokh Casas, Estephany
    Martinez, Nieves Purificacion
    Herranz, Urbano Anido
    Cabezas Agricola, Jose Manuel
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    Calvo, Ovidio Fernandez
    Mato Mato, Jose Antonio
    Seoane, Zulema Nogareda
    Martinez de LLano, Sofia Rodriguez
    Varela, Maria Quindos
    Baron, Francisco
    Fonseca, Omar Rodriguez
    Castineira, Antia Cousillas
    Garcia, Gloria Muniz
    De Matias Leralta, Jose Maria
    Catalina, Pablo Fernandez
    Cameselle Teijeiro, Jose Manuel
    Bernardez, Beatriz
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).
    Abou Jokh Casas, Estephany
    Lago, Nieves Martinez
    Cabezas Agricola, Jose Manuel
    Herranz, Urbano Anido
    Baron, Francisco
    Calvo, Ovidio Fernandez
    Varela, Maria Quindos
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    De Matias Leralta, Jose Maria
    Seoane, Zulema Nogareda
    Castineira, Antia Cousillas
    Martinez de LLano, Sofia Rodriguez
    Mato Mato, Jose Antonio
    Catalina, Pablo Fernandez
    Fonseca, Omar Rodriguez
    Garcia, Gloria Muniz
    Bernardez, Beatriz
    Cameselle Teijeiro, Jose Manuel
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [3] Can tumor absorbed dose predict response to Peptide Receptor Radionuclide Therapy (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)?
    Mileva, M.
    Marin, G.
    Levillain, H.
    van Bogaert, C.
    Critchi, G.
    Marin, C.
    Flamen, P.
    Karfis, I
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 153 - 153
  • [4] Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
    Bergsma, Hendrik
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Herder, Wouter W.
    Peeters, Robin P.
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) : 867 - 881
  • [5] Peptide receptor radionuclide therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): From literature to practice
    Bournaud, C.
    Kelly, A.
    Hindie, E.
    Tenenbaum, F.
    Faivre-Chauvet, A.
    Courbon, F.
    Taieb, D.
    Dierickx, L. O.
    Coriat, R.
    Ansquer, C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2017, 41 (01): : 42 - 54
  • [6] Utility of Midpoint Imaging in Patients Receiving Peptide Receptor Radionuclide Therapy (PRRT) for Advance Progressive Gastroenteropancreatic-Neuroendocrine Tumors (GEP-NETs)
    Norman, Aurora P.
    Wee, Christopher
    Hobday, Timothy J.
    Kendi, Ayse T.
    Johnson, Geoffrey B.
    Thorpe, Matthew P.
    Lunn, Brendan W.
    Bach, Corrie R.
    Halfdanarson, Thorvardur R.
    PANCREAS, 2022, 51 (03) : E45 - E45
  • [7] Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis
    Casas, E. Abou-Jokh
    Martinez-Lagob, N.
    Araujo, M. C. Mallon
    Agricolac, J. M. Cabezas
    Seoaned, Z. Nogareda
    Castineirae, A. Cousillas
    Morellf, A. Ruibal
    Nuneza, V. Pubul
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (03): : 156 - 162
  • [8] PFS and OS after Salvage Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors (GEP-NETs) - The Rotterdam Cohort
    Van der Zwan, W.
    Brabander, T.
    Kam, B.
    Teunissen, J.
    Krenning, E.
    Kwekkeboom, D.
    de Herder, W.
    NEUROENDOCRINOLOGY, 2018, 106 : 262 - 262
  • [9] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Kizilgul, Muhammed
    Delibasi, Tuncay
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (01) : 39 - 56
  • [10] GEP-NETS UPDATE Radionuclide therapy in neuroendocrine tumors
    van der Zwan, Wouter A.
    Bodei, Lisa
    Mueller-Brand, Jan
    de Herder, Wouter W.
    Kvols, Larry K.
    Kwekkeboom, Dik J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (01) : R1 - R8
12345